| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |